Fate of Patients with Adenocarcinoma of the Esophagus and the Esophagogastric Junction: A Population-Based Analysis

American Journal of Gastroenterology

Volumn 99, Issue 3, 2004, Pages 419-424

  Sihvo, Eero I T ^b   Luostarinen, Markku E ^b   Salo, Jarmo A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; ENDOSCOPIC THERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; FINLAND; HUMAN; LOWER ESOPHAGUS SPHINCTER; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY;

EID: 1942440392     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajg200483     Document Type: Article

References (30)

1. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
2. Matthews HR, Waterhouse JAH, Powell J, et al., eds. Clinical Cancer Monographs. In: Cancer of the oesophagus. London: Macmillan, 1987:1.
3. Turnbull AD, Goodner JT. Primary adenocarcinoma of the esophagus. Cancer 1968;22:915-8.
4. Allum WH, Roginski C, Fielding JWL, et al. Adenocarcinoma of the cardia: A 10-year regional review. World J Surg 1986;10:462-7.
5. Daly JM, Fry WA, Little AG, et al. Esophageal cancer: Results of an American College of Surgeons patient care evaluation study. J Am Coll Surg 2000;190:562-72.
6. Hulscher JBF, Tijssen JGP, Obertop H, et al. Transthoracic versus transhiatal resection for carcinoma of the esophagus: A meta-analysis. Ann Thorac Surg 2001;72:306-13.
7. Sihvo EIT, Pentikäinen TJ, Luostarinen ME, et al. Inoperable adenocarcinoma of the oesophagogastric junction: A comparative clinical study of laser coagulation versus self-expanding metallic stents with special reference to cost analysis. EJSO 2002;28:711-5.
8. World Health Organization. International classification of diseases for oncology. Geneva: WHO; 1976.
9. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994;33:365-9.
10. Hölscher AH, Bollschweiler E, Siewert JR. Carcinoma of the gastric cardia. Ann Chir Gyn 1995;84:185-92.
11. UICC (International Union Against Cancer). In: Sobin LH, Wittekind Ch, eds. TNM classification of malignant tumors, 5th Ed. New York: Wiley-Liss, 1997:59-62.
12. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 1980;67:381-90.
13. Siewert JR, Feith M, Werner M, et al. Adenocarcinoma of the esophagogastric junction: Results of surgical therapy based on anatomical topographic classification in 1,002 consecutive patients. Ann Surg 2000;232:353-61.
14. Collard JM. Exclusive radical surgery for esophageal adenocarcinoma. Cancer 2001;91:1098-104.
15. Swisher SG, DeFord L, Merriman KW, et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 2000;119:1126-32.
16. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:1623-7.
17. Khansur T, Allred C, Tavassoli M. 5-fluorouracil, adriamycin, and mitomycin C in adenocarcinoma of the esophagus or gastroesophageal junction tumors. Am J Clin Oncol 1994;17:506-8.
18. Hejna M, Kornek GV, Schratter-Sehn AU, et al. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma. Cancer 1996;78:1646-50.
19. Enzinger PC, Ilson DH, Kelsen DP. Chemotherapy in esophageal cancer. Semin Oncol 1999;26(suppl 15):12-20.
20. Coia LR, Paul AR, Engstrom PF. Combined radiation and chemotherapy as primary management of adenocarcinoma of the esophagus and gastroesophageal junction. Cancer 1988;61:643-9.
21. Adam A, Ellul J, Watkinson AF, et al. Palliation of inoperable esophageal carcinoma: A prospective randomized trial of laser therapy and stent placement. Radiology 1997;202:344-8.
22. De Palma GD, di Matteo E, Romano G, et al. Plastic prosthesis versus expandable metal stents for palliation of inoperable esophageal thoracic carcinoma: a controlled prospective study. Gastrointest Endosc 1996;43:478-82.
23. Blazeby JM, Farndon JR, Donovan J, et al. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 2000;88:1781-7.
24. Hölscher AH, Bollschweiler E, Bumm R, et al. Prognostic factors of resected adenocarcinoma of the esophagus. Surgery 1995;118:845-55.
25. Hulscher JBF, van Sandick JW, de Boer AGEM, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662-9.
26. Nigro JJ, DeMeester SR, Hagen JA, et al. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg 1999;117:960-8.
27. Hagen JA, DeMeester SR, Peters JH, et al. Curative resection for esophageal adenocarcinoma: Analysis of 100 en bloc esophagectomies. Ann Surg 2001;234:520-31.
28. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-7.
29. Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomised controlled trial. Lancet 2002;359:1727-33.
30. Heath EI, Burtness BA, Heitmiller RF, et al. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol 2000;18:868-76.